Showing results (21-30 of 35) with videos related to
Sort By:
Pageof 4
Arthritis & Rheumatology (Hoboken, N.J.)|December 18, 2025
Risk factors for relapse in ANCA-associated vasculitis among patients with relapse after induction of remission with rituximabEllen Romich, Joshua F Baker, Thomas R Riley, et al.Trials|March 14, 2023
PROphylaxis for paTiEnts at risk of COVID-19 infecTion (PROTECT-V)Toby J L Humphrey, Davinder Dosanjh, Thomas F Hiemstra, et al.Autoimmunity Reviews|October 31, 2021
The COVID-19 pandemic and ANCA-associated vasculitis - reports from the EUVAS meeting and EUVAS education forumAndreas Kronbichler, Duvuru Geetha, Rona M Smith, et al.BMJ Open|July 17, 2024
Study protocol for a randomised, phase II, double-blind, experimental medicine study of obinutuzumab versus rituximab in ANCA-associated vasculitis: ObiVasDominic Paul McGovern, Mark E McClure, Matthew Coates, et al.Arthritis & Rheumatology (Hoboken, N.J.)|May 19, 2019
Rituximab as Maintenance Treatment for Systemic Lupus Erythematosus: A Multicenter Observational Study of 147 PatientsMatthias A Cassia, Federico Alberici, Rachel B Jones, et al.Trials|October 15, 2025
A pragmatic, randomised, open-label, multi-centre UK registry-facilitated trial evaluating the effect of high-dose cholecalciferol on mortality in patients on dialysis: the SIMPLIFIED trialToby J L Humphrey, Fergus J Caskey, David C Wheeler, et al.Annals of the Rheumatic Diseases|January 26, 2023
Risk factors for serious infections in ANCA-associated vasculitisBalazs Odler, Regina Riedl, Philipp Gauckler, et al.Arthritis & Rheumatology (Hoboken, N.J.)|March 22, 2021
Risk Factors for Severe Outcomes in Patients With Systemic Vasculitis and COVID-19: A Binational, Registry-Based Cohort StudyMatthew A Rutherford, Jennifer Scott, Maira Karabayas, et al.BMC Nephrology|June 1, 2022
SARS-COV-2 vaccine responses in renal patient populationsRona M Smith, Daniel J Cooper, Rainer Doffinger, et al.Science Advances|February 12, 2025
Humoral responses to SARS-CoV-2 vaccine in vasculitis-related immune suppressionKimia Kamelian, Benjamin Sievers, Michael Chen-Xu, et al.Pageof 4